Team:Rice University/CONSTRUCTS
From 2008.igem.org
(Difference between revisions)
StevensonT (Talk | contribs) (→Constructs) |
(→Constructs) |
||
Line 19: | Line 19: | ||
==='''Constructs'''=== | ==='''Constructs'''=== | ||
- | <p>''Saccharomyces cerevisiae'' is widely used for baking and brewing, a versatile eukaryotic model system, and particularly useful for synthesizing metabolites under fermentation conditions. The microaerobic conditions of fermentation impede the oxidation of sensitive bioreactive compounds and are optimal for the ''de novo'' synthesis of resveratrol. To achieve our project goals and expand the yeast synthetic biology toolbox, we have constructed BioBricks encoding 3 yeast promoters, 3 yeast terminators, a | + | <p>''Saccharomyces cerevisiae'' is widely used for baking and brewing, a versatile eukaryotic model system, and particularly useful for synthesizing metabolites under fermentation conditions. The microaerobic conditions of fermentation impede the oxidation of sensitive bioreactive compounds and are optimal for the ''de novo'' synthesis of resveratrol. To achieve our project goals and expand the yeast synthetic biology toolbox, we have constructed BioBricks encoding 3 yeast promoters, 3 yeast terminators, a 2-micron origin of replication, 2 selectable markers, 2 metabolic enzymes, and a yeast integration plasmid. We have also submitted two additional parts representing foundational tools, including a gene encoding an amber suppressed RFP biobrick for screening of SupF+ (Amber suppressor) genotype and an amber suppressor tRNA biobrick. <br /> |
</p> | </p> | ||
Line 30: | Line 30: | ||
<td width="120">[http://partsregistry.org/wiki/index.php?title=Part:BBa_K122000 BBa_K122000]</td> | <td width="120">[http://partsregistry.org/wiki/index.php?title=Part:BBa_K122000 BBa_K122000]</td> | ||
<td width="118">pPGK1</td> | <td width="118">pPGK1</td> | ||
- | <td width="466">1500 bp upstream of the PGK1 coding region. Strongly induced during fermentation. </td> | + | <td width="466">~1500 bp upstream of the PGK1 coding region. Strongly induced during fermentation. </td> |
- | <td width="24"> | + | <td width="24">1497bp</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>[http://partsregistry.org/wiki/index.php?title=Part:BBa_K122002 BBa_K122002]</td> | <td>[http://partsregistry.org/wiki/index.php?title=Part:BBa_K122002 BBa_K122002]</td> | ||
<td>pADH1</td> | <td>pADH1</td> | ||
- | <td>700bp upstream of ADH1 promoter region. Constitutive promoter.</td> | + | <td>700bp upstream of ADH1 promoter region. Constitutive promoter under aerobic and anaerobic conditions.</td> |
<td>701</td> | <td>701</td> | ||
</tr> | </tr> | ||
Line 43: | Line 43: | ||
<td>pGAL1 + tetO</td> | <td>pGAL1 + tetO</td> | ||
<td>Glucose repressible / galactose inducible GAL1 promoter. An additional TetR operator site was included to allow repression by TetR.</td> | <td>Glucose repressible / galactose inducible GAL1 promoter. An additional TetR operator site was included to allow repression by TetR.</td> | ||
- | <td> | + | <td>484bp</td> |
</tr> | </tr> | ||
</table> | </table> | ||
Line 55: | Line 55: | ||
<td width="74">tCYC1</td> | <td width="74">tCYC1</td> | ||
<td width="493">300bp downstream the CYC1 coding region in a standard yeast strain.</td> | <td width="493">300bp downstream the CYC1 coding region in a standard yeast strain.</td> | ||
- | <td width="46"> | + | <td width="46">300bp</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 61: | Line 61: | ||
<td>tADH1</td> | <td>tADH1</td> | ||
<td>300bp downstream the ADH1 coding region in a standard yeast strain.</td> | <td>300bp downstream the ADH1 coding region in a standard yeast strain.</td> | ||
- | <td> | + | <td>300bp</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 67: | Line 67: | ||
<td>tPGK1</td> | <td>tPGK1</td> | ||
<td>1000bp downstream the PGK1 coding region in an industrial yeast strain.</td> | <td>1000bp downstream the PGK1 coding region in an industrial yeast strain.</td> | ||
- | <td> | + | <td>1000bp</td> |
</tr> | </tr> | ||
</table> | </table> | ||
Line 79: | Line 79: | ||
<td width="74">ZeoR</td> | <td width="74">ZeoR</td> | ||
<td width="493">Zeocin/Bleocin Resistance Gene</td> | <td width="493">Zeocin/Bleocin Resistance Gene</td> | ||
- | <td width="46"> | + | <td width="46">300bp</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 85: | Line 85: | ||
<td>BleoR</td> | <td>BleoR</td> | ||
<td>Bleocin Resistance Gene under pTet promoter</td> | <td>Bleocin Resistance Gene under pTet promoter</td> | ||
- | <td> | + | <td>80-bp ish</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>[http://partsregistry.org/wiki/index.php?title=Part:BBa_K122014 BBa_K122014]</td> | <td>[http://partsregistry.org/wiki/index.php?title=Part:BBa_K122014 BBa_K122014]</td> | ||
<td>ORI+HisTag</td> | <td>ORI+HisTag</td> | ||
- | <td>2 Micron ORI and auxotrophic | + | <td>2 Micron ORI and auxotrophic histidine marker </td> |
- | <td>< | + | <td><9000bp</td> |
</tr> | </tr> | ||
</table> | </table> | ||
Line 108: | Line 108: | ||
<td>Tyrosine Ammonia Lyase</td> | <td>Tyrosine Ammonia Lyase</td> | ||
<td>[[Image:TAL.jpg|50px]]</td> | <td>[[Image:TAL.jpg|50px]]</td> | ||
- | <td> | + | <td>1933bp</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 114: | Line 114: | ||
<td>4-coumarate CoA ligase :: Stilbene Synthase Fusion Protein</td> | <td>4-coumarate CoA ligase :: Stilbene Synthase Fusion Protein</td> | ||
<td>[[Image:4CL.jpg|50px]]</td> | <td>[[Image:4CL.jpg|50px]]</td> | ||
- | <td> | + | <td>4000bp</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 120: | Line 120: | ||
<td>[pPGK1][4CL:STS][tCYC1]</td> | <td>[pPGK1][4CL:STS][tCYC1]</td> | ||
<td>[[Image:C1.jpg|150px]]</td> | <td>[[Image:C1.jpg|150px]]</td> | ||
- | <td> | + | <td>5497bp</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 126: | Line 126: | ||
<td>[pGAL1][tetO][ZeoR][tADH1]</td> | <td>[pGAL1][tetO][ZeoR][tADH1]</td> | ||
<td>[[Image:C2full.jpg|150px]]</td> | <td>[[Image:C2full.jpg|150px]]</td> | ||
- | <td> | + | <td>1175bp</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 132: | Line 132: | ||
<td>[pADH1][TAL][tPGK1]</td> | <td>[pADH1][TAL][tPGK1]</td> | ||
<td>[[Image:C3.jpg|150px]]</td> | <td>[[Image:C3.jpg|150px]]</td> | ||
- | <td> | + | <td>2651bp</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 138: | Line 138: | ||
<td>[pPGK1][4CL:STS][tCYC1][pGAL1][tetO][ZeoR][tADH1]</td> | <td>[pPGK1][4CL:STS][tCYC1][pGAL1][tetO][ZeoR][tADH1]</td> | ||
<td>[[Image:C1C2C3.jpg|350px]]</td> | <td>[[Image:C1C2C3.jpg|350px]]</td> | ||
- | <td> | + | <td>1824bp</td> |
</tr> | </tr> | ||
</table> | </table> |
Revision as of 05:15, 30 October 2008
|